4519 — Chugai Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Chugai Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	214,733	302,995	374,429	325,472	387,317
Depreciation
Amortisation
Non-Cash Items	92,641	133,165	167,061	101,347	165,197
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-132,714	-187,402	-328,812	-48,635	-136,579
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	205,036	279,626	244,112	409,924	447,600
Capital Expenditures	-61,411	-72,866	-71,239	-74,258	-54,899
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-36,901	-46,061	-74,755	36,968	-172,466
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-98,312	-118,927	-145,994	-37,290	-227,365
Financing Cash Flow Items	-33	-47	-58	-81	233
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-99,497	-107,408	-145,641	-139,331	-141,006
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,393	55,419	-45,584	236,505	81,528